BSG National Introduction to Gastroenterology

Friday 13 November 2015 - Council Chamber, Royal College of Physicians

The BSG is holding its first introductory day for newcomers into higher specialist training. Our main aim is to welcome them to our great specialty but particularly to encourage them to look into the future not so much as the training programme ahead of them but beyond that into a career in gastroenterology.

We feel that many trainees focus on their training years that lie ahead and so don't take a long view about training as a pathway to prepare them for their eventual career as a specialist.

The morning comprises a series of introductory talks from senior gastroenterologists who have wide experience of training. In the afternoon there will be a series of 'Musical Tables', which will commence after lunch and continue after tea. Between 10-12 trainees will rotate around separate tables which will be hosted by a gastroenterologist and a trainee where a series of relevant topics will be presented and discussed in a more informal manner.

The BSG Training Committee, the BSG Trainees' Section and your regional Training Programme Director all support this very important day and strongly encourage you to come along. It may very well be that the consultants where you are working are aware that you won't be in the hospital that day but we do advise you to check this and book your study leave for the day. There is no attendance fee, lunch and refreshments are provided and the BSG will reimburse your travel expenses (but you must please take advantage of any advanced booking discounts if using the railway).

Please contact Janet Bassett ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ) to reserve your place.


BSG/RCP joint conference: 'GI Cancer in the UK: Can we do better?'

"GI Cancer in the UK: Can we do better?" will take place at the Royal College of Physicians and is co-badged by the British Society of Gastroenterology (BSG).

BSG members can benefit from a reduced registration fee. Please follow the link below to book your place. Do so early to avoid disappointment. This conference is focused upon gastrointestinal cancer survival in the UK. With published outcomes in this country bearing unfavourable comparison with Europe, this meeting is set to explore the potential for the UK to do better - with the emphasis being very much on prevention and earlier detection. It also follows the recent publication of the Independent Cancer Taskforce's Cancer Strategy for England "Achieving World-Class Cancer Outcomes". The BSG hopes you will be able to attend what promises to be an excellent event with a high calibre programme of speakers.

The conference will provide a forum to cover:

  • prevention
  • screening
  • new pathways to earlier diagnosis
  • the primary and secondary interface
  • managing demand and capacity in endoscopy
  • improving detection.





National survey on faecal transplantation for C. difficile

Dear Doctor,
We would be grateful if you could kindly spare 2 minutes of your time to participate in this very short national survey exploring your centre's practices for faecal microbiota transplantation (FMT). To date there has been very limited experience of its use the United Kingdom for treating recurrent and refractory Clostridium difficile infection and the reasons for this remain unclear. It is also apparent from published studies that the patient and donor selection criteria, stool characteristics and mode of administration are not standardised and vary from centre to centre. We intend to survey the practices of faecal transplantation for Clostridium difficile infection across the UK and understand barriers involved in setting this up locally. We would really appreciate your help in this. This survey is led by Professor Tariq Iqbal (University Hospital Birmingham), Dr Ailsa Hart (St Marks Hospital), Dr Alaric Colville (Royal Devon and Exeter Hospital), Professor Peter Hawkey (University of Birmingham) and Dr Horace Williams (Imperial College Healthcare Trust). The survey is split into two parts. The first part involves a very short online survey (which closes 31 October); if you agree to take part in the second part of the survey, we would then contact you for 5 minute phone conversation.
Thank you,
Yours sincerely,
M Nabil Quraishi
Gastro SpR
University Hospital Birmingham



Cancer Genetics in Clinical Practice

A Guide to Cancer Genetics in Clinical Practice

A Guide to Cancer Genetics in Clinical Practice

BSG member Sue Clark has recently published a new textbook 'A GUIDE TO CANCER GENETICS IN CLINICAL PRACTICE' which has a significant gastroenterology content.

This book covers the basic concepts of cancer genetics. The common inherited cancer syndromes are each dealt with in greater depth, with the current management outlined. It is aimed at all clinicians who may encounter these conditions in their practice. The book sets out to facilitate identification of high-risk individuals and families, to inform interaction with geneticists and other sub-specialists, to provide a basis for patient management and to stimulate interest in these fascinating conditions.

View Flyer / Purchasing Details [ 38 Kb ]

Publication date: June 2009


BSG Guidance on Coeliac Disease 2010

The Management of Adults with Coeliac Disease


There is clear evidence that coeliac disease is a common gastrointestinal disease affecting up to 1% of the adult population. Individuals may go undetected for many years. This is despite multiple presentations to both primary and secondary care. This may reflect that fact that affected individuals have subtle gastrointestinal symptoms or no gastrointestinal symptoms.

An active case finding strategy will increase the number of patients detected with coeliac disease. Testing for coeliac disease should incorporate an IgA level, Tissue Transglutaminase antibody and/or Endomysial antibody (depending on what is locally available). In patients with a positive antibody a duodenal biopsy should be undertaken to confirm the presence of villous atrophy. In patients who are antibody negative but the clinician is suspicious then a duodenal biopsy should still be undertaken having ensured that the patient is not on a self-imposed gluten-free diet (GFD).

The cornerstone of treatment is a GFD. Patients require regular dietetic support with the opportunity or access to a gastroenterologist should further problems arise. Follow-up may be in primary or secondary care as long as the support is adequate (as noted previously).

In patients with persisting symptoms they should be investigated carefully with particular reference to ensuring that refractory coeliac disease is excluded.


Page 4 of 16